Sphera Funds Management Ltd. 13D and 13G filings for Skye Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 5:27 pm Purchase |
2025-03-31 | 13G | Skye Bioscience, Inc. SKYE |
Sphera Funds Management Ltd. | 1,476,353 4.770% |
174,835 (+13.43%) |
Filing |
| 2024-02-08 09:51 am Purchase |
2024-01-29 | 13G | Skye Bioscience, Inc. SKYE |
Sphera Funds Management Ltd. | 1,301,518 5.390% |
1,301,518 (New Position) |
Filing |